Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiajun Deng

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Annals of Translational Medicine|May 13, 2020
A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratioJiani Gao, Yijiu Ren, Haoyue Guo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 25, 2021
Proposal for Rib invasion as an independent T descriptor for non-small cell lung cancer: A propensity-score matching analysisMengmeng Zhao, Junqi Wu, Jiajun Deng, et al.
Lung Cancer (Amsterdam, Netherlands)|February 6, 2024
Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinomaShenghao Huang, Mengmeng Zhao, Shenghui Li, et al.
Radiology|October 26, 2021
Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung CancerYifan Zhong, Yunlang She, Jiajun Deng, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 19, 2024
Long-term prognostic characteristics of patients with clinical stage IA part-solid lung adenocarcinoma: a conditional survival analysisXinchen Shen, Mengmeng Zhao, Jiajun Deng, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2022
Clinicopathologic characteristics and prognostic impact of atypical EGFR mutations in completely resected lung adenocarcinomaYunlang She, Shenghui Li, Jiajun Deng, et al.
Translational Lung Cancer Research|July 8, 2024
Predicting complication risks after sleeve lobectomy for non-small cell lung cancerYiming He, Lin Huang, Jiajun Deng, et al.
Nature Communications|November 19, 2023
PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancerYifan Zhong, Chuang Cai, Tao Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2023
PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter studyYifan Zhong, Chuang Cai, Tao Chen, et al.
European Radiology|July 18, 2023
Clinical utility of [<sup>18</sup>F]FDG PET/CT in the assessment of mediastinal lymph node disease after neoadjuvant chemoimmunotherapy for non-small cell lung cancerLei Zhang, Haoran E, Jia Huang, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Annals of Translational Medicine|May 13, 2020
A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratioJiani Gao, Yijiu Ren, Haoyue Guo, et al.
Lung Cancer (Amsterdam, Netherlands)|July 25, 2021
Proposal for Rib invasion as an independent T descriptor for non-small cell lung cancer: A propensity-score matching analysisMengmeng Zhao, Junqi Wu, Jiajun Deng, et al.
Lung Cancer (Amsterdam, Netherlands)|February 6, 2024
Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinomaShenghao Huang, Mengmeng Zhao, Shenghui Li, et al.
Radiology|October 26, 2021
Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung CancerYifan Zhong, Yunlang She, Jiajun Deng, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 19, 2024
Long-term prognostic characteristics of patients with clinical stage IA part-solid lung adenocarcinoma: a conditional survival analysisXinchen Shen, Mengmeng Zhao, Jiajun Deng, et al.
European Journal of Cancer (Oxford, England : 1990)|November 2, 2022
Clinicopathologic characteristics and prognostic impact of atypical EGFR mutations in completely resected lung adenocarcinomaYunlang She, Shenghui Li, Jiajun Deng, et al.
Translational Lung Cancer Research|July 8, 2024
Predicting complication risks after sleeve lobectomy for non-small cell lung cancerYiming He, Lin Huang, Jiajun Deng, et al.
Nature Communications|November 19, 2023
PET/CT based cross-modal deep learning signature to predict occult nodal metastasis in lung cancerYifan Zhong, Chuang Cai, Tao Chen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2023
PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter studyYifan Zhong, Chuang Cai, Tao Chen, et al.
European Radiology|July 18, 2023
Clinical utility of [<sup>18</sup>F]FDG PET/CT in the assessment of mediastinal lymph node disease after neoadjuvant chemoimmunotherapy for non-small cell lung cancerLei Zhang, Haoran E, Jia Huang, et al.
Pageof 9